Europe Women's Health Market Size & Outlook, 2025-2030

The women's health market in Europe is expected to reach a projected revenue of US$ 18,508.5 million by 2030. A compound annual growth rate of 5.1% is expected of Europe women's health market from 2025 to 2030.
Revenue, 2024 (US$M)
$13,365.1
Forecast, 2030 (US$M)
$18,508.5
CAGR, 2025 - 2030
5.1%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe women's health market, 2018-2030 (US$M)

Europe women's health market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe women's health market highlights

  • The Europe women's health market generated a revenue of USD 13,365.1 million in 2024.
  • The market is expected to grow at a CAGR of 5.1% from 2025 to 2030.
  • In terms of segment, contraceptives was the largest revenue generating application in 2024.
  • Menopause is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, Italy is expected to register the highest CAGR from 2025 to 2030.


Europe data book summary

Market revenue in 2024USD 13,365.1 million
Market revenue in 2030USD 18,508.5 million
Growth rate5.1% (CAGR from 2025 to 2030)
Largest segmentContraceptives
Fastest growing segmentMenopause
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPostmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Hormonal Infertility, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)
Key market players worldwideAbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring


Other key industry trends

  • In terms of revenue, Europe region accounted for 27.1% of the global women's health market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 17,554.4 million by 2030.

Contraceptives was the largest segment with a revenue share of 35.09% in 2024. Horizon Databook has segmented the Europe women's health market based on postmenopausal osteoporosis, endometriosis & uterine fibroids, hormonal infertility, contraceptives, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.


The growing population of elderly women is one of the key factors anticipated to increase the prevalence of women’s health issues in Europe. According to Eurostat, approximately 43% of European women are aged above 65.

Various initiatives undertaken by government agencies and NGOs, such as the European Institute of Women’s Health (EIWH) and Women’s Health Organization, to raise awareness about women’s health are anticipated to positively impact the market.

The increasing number of market players involved in manufacturing women's health products in European countries and the growing prevalence of various women’s health issues, such as postmenopausal symptoms, PCOS, & infertility, are anticipated to boost the market. The EMA evaluates the application for human use.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Companies

Name Profile # Employees HQ Website
Apothecus View profile 11-50 Hicksville, New York, United States, North America https://apothecus.com
Blairex Laboratories View profile 101-250 Columbus, Indiana, United States, North America http://www.blairex.com
Agile Therapeutics Inc View profile 19 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 https://www.agiletherapeutics.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

Europe women's health market size, by country, 2018-2030 (US$M)

Europe Women's Health Market Outlook Share, 2024 & 2030 (US$M)

Europe women's health market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online